Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Phase II Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia
25 února, 2021 4:29 pmProgram: Oral and Poster Abstracts Type: Oral Session: 311. Disorders of Platelet Number or Function: Advances in ITP...
Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia
25 února, 2021 4:23 pmProgram: Oral and Poster Abstracts Type: Oral Session: 311. Disorders of Platelet Number or Function: Clinical Insights into...
Imunitní trombocytopenie – zajímavosti z ASH®
25 února, 2021 4:14 pmV rámci každoročního kongresu Americké hematologické společnosti, který se konal ve dnech 7.–10. prosince 2019 v Orlandu na Floridě (Spojené státy americké)...
PEGASPARGASE CAN SAFELY BE ADMINISTERED IN ADULTS AGE 40 AND OLDER WITH ACUTE LYMPHOBLASTIC LEUKEMIA
25 února, 2021 4:02 pmProgram: Oral and Poster Abstracts Type: Oral Session: 612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster III Hematology...
Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg
25 února, 2021 3:59 pmProgram: Oral and Poster Abstracts Session: 642. CLL: Therapy, excluding Transplantation: Poster I Hematology Disease Topics & Pathways:...
A Multicentre, Retrospective Observational Study to Evaluate the Clinical Outcomes of Patients with Chronic Lymphocytic Leukaemia (CLL) Treated with Idelalisib and Rituximab in the UK (RETRO-idel) – a Cohort of 110 Patients
25 února, 2021 3:56 pmProgram: Oral and Poster Abstracts Session: 642. CLL: Therapy, excluding Transplantation: Poster I Hematology Disease Topics & Pathways:...
Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis
25 února, 2021 3:53 pmProgram: Oral and Poster Abstracts Session: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma – Clinical Studies: Poster I ...
The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
25 února, 2021 3:48 pmProgram: Oral and Poster Abstracts Type: Oral Session: 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell...
Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
25 února, 2021 3:43 pmProgram: Oral and Poster Abstracts Type: Oral Session: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma – Clinical Studies:...
Chronická lymfocytární leukemie a maligní lymfomy na ASH® 2019
25 února, 2021 3:38 pmLetošní, 61. kongres Americké hematologické společnosti byl podobně jako kongres Evropské hematologické společnosti v oblasti chronické lymfocytární leukemie (CLL) i lymfomů zaměřen...